Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Ozempic
Ozempic
Page 3 of 8
Tech
Merck snags Chinese obesity drug in nearly $2 billion deal
By
Robert Langreth
and
Bloomberg
December 19, 2024
Tech
Novo Nordisk invests $1.2 billion in new Danish factory to expand beyond insulin and weight-loss
By
AFP
December 16, 2024
Health
Zepbound vs. Wegovy: New clinical trial says this weight-loss medication sheds more pounds
By
Lindsey Leake
December 4, 2024
Health
Ozempic covered by Medicare? It could be if Trump agrees to a Biden proposal with a $35 billion price tag
By
The Associated Press
November 27, 2024
Health
Novo Nordisk Foundation CEO dismisses ‘Nokia risk’ as ‘fundamentally different’ for Denmark’s economy
By
Ryan Hogg
November 26, 2024
Health
Biden proposes Medicare and Medicaid cover weight-loss drugs like Wegovy and Ozempic for millions of obese Americans
By
Amanda Seitz
and
The Associated Press
November 26, 2024
Leadership
High demand for weight loss drugs like Ozempic and Wegovy is impacting employer health care costs—but it can be critical for retaining talent
By
Brit Morse
November 21, 2024
Retail
Novo Nordisk’s Wegovy sales jump on international rollouts
By
Naomi Kresge
and
Bloomberg
November 6, 2024
Health
Novo’s main Ozempic plant cited for quality lapses by FDA
By
Madison Muller
and
Bloomberg
October 29, 2024
Health
Drugs like Ozempic and Wegovy are linked to a lower risk of Alzheimer’s disease, new study says
By
Ani Freedman
October 24, 2024
Commentary
Ozempic and Wegovy are trimming waistlines—and showing how quickly U.S. health care can turn into a gold rush
By
Owen Tripp
October 23, 2024
Success
Unemployed Brits will receive free Ozempic-style weight-loss shots to help them get jobs
By
Orianna Rosa Royle
October 17, 2024
Health
Companies are more willing to consider covering weight-loss drugs
By
Chris Morris
October 10, 2024
Health
Most Americans who want to lose weight don’t want to take GLP-1 drugs like Wegovy and Zepbound, new survey says
By
Lindsey Leake
October 10, 2024
Finance
Pfizer stock surges 3% after activist Starboard takes $1 billion stake, taps former execs
By
Greg McKenna
October 7, 2024
Most Popular
Economy
America's $38 trillion national debt 'exacerbates generational imbalances' with Gen Z and millennials paying the price,...
By
Eleanor Pringle
Success
As millions of Gen Zers face unemployment, McDonald's CEO dishes out some tough love career...
By
Preston Fore
Innovation
An MIT roboticist who cofounded bankrupt Roomba maker iRobot says Elon Musk's vision of humanoid robot assistants is...
By
Marco Quiroz-Gutierrez